HKD 3.39
(-0.29%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | -611.21 Million CNY | -12.32% |
2022 | 1.02 Billion CNY | -20.63% |
2021 | 1.29 Billion CNY | -4.39% |
2020 | 1.35 Billion CNY | 81.74% |
2019 | 745.05 Million CNY | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q2 | 388.29 Million CNY | 137.2% |
2023 Q2 | 432.64 Million CNY | -20.77% |
2023 Q4 | -1.04 Billion CNY | -341.27% |
2023 FY | 901.01 Million CNY | -12.32% |
2022 Q4 | 546.03 Million CNY | 0.0% |
2022 FY | 1.02 Billion CNY | -20.63% |
2021 FY | 1.29 Billion CNY | -4.39% |
2020 FY | 1.35 Billion CNY | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Uni-Bio Science Group Limited | 392.81 Million HKD | 255.597% |
CK Life Sciences Int'l., (Holdings) Inc. | 947.7 Million HKD | 164.494% |